Wednesday, August 2, 2023

Fw: Ref.: LML) Fixed duration multidrug therapy (12 months) in leprosy patients with high bacillary load – Need to look beyond

 

Leprosy Mailing List – August 2,  2023

Ref.:  LML) Fixed duration multidrug therapy (12 months) in leprosy patients with high bacillary load – Need to look beyond

FromBen Naafs and Pieter Schreuder, the Netherlands


 

 

Dear colleagues,

 

Recently, in the Indian Journal of Dermatology, Venerology and Leprology the following interesting article appeared:

Narang T, Almeida JG, Kumar B, Rao PN, Frade MAC, et al. Fixed duration multidrug therapy (12 months) in Hansen's disease patients with high bacillary load – need to look beyond. Indian J Dermatol Venereol Leprol

doi: 10.25259/IJDVL_278_2023

The conclusion of the article:

"Patients with high bacillary load suffer repeated reactions, progressive nerve function impairment and worsening of disabilities.  They also experience endogenous relapse and exogenous reinfection.  This ensures transmission even in well-run control programmes. Choosing one or a combination of the following options in highly bacillated patients is likely to help protect patients as well as the general population."  See attached file for the complete article and its recommendations!


Just to remind you, the past few years, Joel Almeida has repeatedly discussed the same topic in LML Many of our readers and leprosy workers are confronted with these problems. Hopefully, also the policy makers will be convinced that something has to change. Did not they claim to aim for world without leprosy?

 

Best regards,

 

Ben Naafs

Pieter Schreuder

 


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/883c0414-c1f1-4930-9377-b2b7e7a9f4e3n%40googlegroups.com.

No comments: